Summary:
Testosterone Replacement therapy for assessment of long-term Vascular Events and efficacy response in hypogonadal men
Qualified Participants Must:
Men 45 to 85
Have low testosterone
Evidence of pre-existing cardiovascular (CV) disease
Sign or symptom of low-T such as decreased sexual desire, decreased energy or fatigue, low mood or depressed mood, loss of body hair
Not on or had history of taking growth hormones, anti-estrogen or estrogen treatment
no history of cancer
Qualified Participants May Receive:
Enrolled patients will potentially receive testosterone replacement therapy or placebo, study related medical care, and compensation for their time and travel.